Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
Diabetes · 01.12.2025 · 74 (12) · 2168-2178
DOI: 10.2337/db25-0120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, online erschienen am 15.07.2025. Verfasst von Ralph A DeFronzo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Division, UT Health and Texas Diabetes Institute, San Antonio, TX. Hauptthemen laut MEDLINE: Cushing Syndrome, Homeostasis, Diabetes Mellitus, Type 2, Glucose. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Until recently, the prevalence of endogenous Cushing syndrome has been considered to be low. However, improved diagnostic strategies and increased awareness have broadened our understanding of hypercortisolism and its role in the pathophysiology of type 2 diabetes, obesity, hypertension, and cardiovascular disease. Recent studies from Europe, South America, and the U.S. have demonstrated that a significant percentage of individuals with difficult-to-control type 2 diabetes, despite treatment with multiple glucose-lowering agents, have hypercortisolism as a causative factor in their poorly managed diabetes. In this review, we examine the pathophysiologic mechanisms via which excess cortisol contributes to the impairment in glucose homeostasis and recommend that hypercortisolism be added to the Ominous Octet to form the Noxious Nine as the pathophysiologic foundation for the development of type 2 diabetes. Article Highlights Hypercortisolism as a causative factor in the development of type 2 diabetes has received scant attention. Studies from Europe, South America, and the U.S. have demonstrated that a significant percentage of individuals with poorly managed type 2 diabetes, despite treatment with multiple glucose-lowering agents, have endogenous hypersecretion of cortisol as a causative factor for their hyperglycemia. In vivo and in vitro studies in animals and humans have demonstrated that excess exposure to glucocorticoids can promote insulin resistance in muscle, liver, and adipocytes and impair insulin secretion. We propose a reverberating cycle in which hypercortisolism disrupts the normal circadian rhythm causing insulin resistance and hyperinsulinemia, which in turn further disrupts the hypothalamic-pituitary-adrenal axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Diabetes Division, UT Health and Texas Diabetes Institute, San Antonio, TX.
- Division of Metabolism, Endocrinology, & Diabetes, University of Michigan School of Medicine and Ann Arbor VA Medical Center, Ann Arbor, MI.
ORCID-Profile: Ralph A DeFronzo
Zitieren
APA
DeFronzo, R. A., & Auchus, R. J. (2025). Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review. Diabetes, 74(12), 2168-2178. https://doi.org/10.2337/db25-0120
Vancouver
DeFronzo RA, Auchus RJ. Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review. Diabetes. 2025;74(12):2168-2178. doi:10.2337/db25-0120
BibTeX
@article{DeFronzo2025,
author = {DeFronzo, Ralph A and Auchus, Richard J},
title = {Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {12},
pages = {2168--2178},
doi = {10.2337/db25-0120}
}
EUVIMED